Sep 21, 2021

Talks with Docs: Douglas Sborov, Multiple Myeloma Director at HCI

Douglas Sborov, MD, MS, discusses the work being done by the multiple myeloma and clinical trials programs at Huntsman Cancer Institute. He also shares why this work is so meaningful and how a Robin Williams character resonates with him in this latest Talks with Docs.

Mar 30, 2021

Letter of Hope from the Multiple Myeloma Program

Though there is currently no cure for multiple myeloma, it is a very treatable disease. The Huntsman Cancer Institute Multiple Myeloma Program and other myeloma research communities continue to press forward in search of a cure. New treatments in the past 15 years have improved survival statistics for patients diagnosed with multiple myeloma, and clinical trials are researching promising therapies.

Mar 24, 2021

Sticking with the Positive through Multiple Myeloma

When Doug Stewart received an MRI after hurting his neck in a biking accident, the images revealed tumors wrapped around his spine. Doug was diagnosed with multiple myeloma. While recovering from his neck injury, he began cancer treatment. Throughout it all, Doug found a way to stay positive and hopeful. Now he has a full life, doing the things he loves and helping others.

Mar 08, 2021

18 Terrible, Wonderful Years: A Multiple Myeloma Patient Shares His Thoughts

“No one is guaranteed tomorrow. But here I am still,” says Dan Bammes, who was diagnosed with multiple myeloma in 2003. Dan says though the cancer-fighting drugs he took had severe side effects, they turned the immediate crisis of his diagnosis into a chronic health issue. He shares his thoughts on living with cancer for the past 18 years and what he has learned about life, death, and appreciating the present.

Nov 11, 2020

Talks with Docs: Tsewang Tashi, Hematologist

Tsewang Tashi., MD, is hematologist and an assistant professor in the division of hematology and hematologic malignancies at the University of Utah. He sees patients at HCI, South Jordan Health Center, and Salt Lake City Veterans Affairs hospital. In this episode of Talks with Docs, he shares with us what lead him to become a physician, what he is most proud of in his work at HCI, and more.

Mar 30, 2020

Ask An Expert: Multiple Myeloma

Multiple myeloma is a rare cancer with many treatment options, though it currently has no cure. We asked our experts at Huntsman Cancer Institute to weigh in on frequently asked questions about multiple myeloma, including how the disease works and how treatment looks.

Mar 25, 2020

The Other Side of the Curtain

Ruth Centurier-Harris and her family came to Salt Lake City from South Africa in 2015, expecting to be here for a short time. Two years later, Ruth received a devastating cancer diagnosis - multiple myeloma. With her husband and three daughters, Ruth embraces the joy of today and making each day special.

Mar 24, 2020

Helping People Is What Brings this Multiple Myeloma Patient Joy

There are many challenges having a blood cancer with no cure. But we just try to enjoy the time we have. After his multiple myeloma diagnosis in 2015, Kenneth Henderson has approached cancer the way he has approached his life–with his whole heart and soul. In 2018, he climbed Mount Kilimanjaro with seven others to raise awareness for blood cancers. The Huntsman Cancer Institute difference, he says, is in the way he was treated: always with kindness and a smile.

Mar 01, 2020

From Notion to Knowledge: Cancer Research Saves Lives

Clinical trials at Huntsman Cancer Institute (HCI) help find better ways to prevent, diagnose, and treat cancer by testing the safety and effectiveness of new drugs and treatments. On average, there are between 150–200 clinical trials open to HCI patients at any given time.

Mar 01, 2020

De la noción al conocimiento: la investigación oncológica salva vidas

Las pruebas clínicas en Huntsman Cancer Institute (HCI por sus siglas en inglés) ayudan a encontrar mejores formas de prevenir, diagnosticar y tratar el cáncer, al poner a prueba la seguridad y efectividad de nuevos fármacos y tratamientos. En promedio, existen 150-200 ensayos clínicos abiertos a pacientes de HCI en cualquier momento dado.

Feb 07, 2020

New CAR-T Target Yields Promising Results for Multiple Myeloma

Too many patients with cancers like multiple myeloma relapse after treatment. This grim reality motivated researchers at HCI to try to improve the depth and durability of treatment response in multiple myeloma through a new cancer cell targeting mechanism. In research published in the journal Nature Communications, HCI scientists describe a novel way to treat cancers using chimeric antigen receptor (CAR) T cell therapy.

Nov 11, 2019

Partnering with the VA to Care for Veterans with Cancer

As a veteran, Frank Luthi was familiar with the Department of Veterans Affairs Salt Lake City Health Care System. The VA offers medical care to enrolled veterans at VA clinics and hospitals. This includes primary care visits and other health services. When Frank was diagnosed with cancer, he didn’t realize he could also get treated by Huntsman Cancer Institute physicians at the VA.

Sep 17, 2019

Blood Cancer Awareness Month

September is Blood Cancer Awareness month. A diagnosis of blood cancer occurs roughly every 3 minutes in the United States. This type of cancer affects millions of families and individuals.

Jun 13, 2019

Grateful to Be a Dad: Celebrating the Opportunity to Have Children after Cancer Treatment

When I was diagnosed with multiple myeloma at the age of 26 it was by far the scariest thing I had ever faced. I had been married for about a year at the time I was diagnosed. At the time I was focused on staying alive, but the incredible team at HCI knew that if being a father was even remotely in the cards (which it was), we needed to take measures to ensure a future family was a possibility.

Mar 01, 2019

Advancing Hematologic Cancer Research and Care

The Center of Excellence in Hematologic Malignancies and Hematology at Huntsman Cancer Institute is a group of more than three dozen doctors and scientists dedicated to hematologic cancers such as leukemia, lymphoma, and multiple myeloma. Integration and collaboration across disciplines will improve clinical care and advance research in these complicated diseases.

Mar 29, 2018

Finding Joy throughout Two Cancer Journeys

“Our perspective was to enjoy life no matter the circumstances. You find joy. Sometimes you have to search under the rug and in the closet, but there’s something to be happy about every day.”

Jul 22, 2015

Poor Survival in Multiple Myeloma Patients Linked to Genetic Variation

As part of a multi-institutional effort, researchers with Huntsman Cancer Institute at the University of Utah have found that multiple myeloma patients with a genetic variation in the gene FOPNL die on average 1-3 years sooner than patients without it.